NCT06616168 - Urogenital Infections in Women of Reproductive Age and the Activity of 4-Thiazolidinone Derivatives Against Pathogens | Biotech Hunter

Enrollment

200

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2027

Conditions

Bacterial Vaginosis

Interventions

DIAGNOSTIC_TEST

Microbiological identification kits (ANAEROtest, STAPHYtest, ENTEROtest, NEFERMtest)

Microbiological identification kits (ANAEROtest, STAPHYtest, ENTEROtest, NEFERMtest) produced by Erba Lachema leads to bacteria detection via biochemical features

DRUG

Antibiotic therapy after the results of antibiotic sensitivity test (Mostly Oxacillin, Benzylpenicillin, Ceftriaxone, Doxycycline, Clindamycin)

Antibiotic therapy after the results of antibiotic sensitivity test. Aminoglycosides, Carbapenems, Cephalosporins, Fluoroquinolones, Oxazolidinones are used. Mostly Oxacillin, Benzylpenicillin, Ceftriaxone, Doxycycline, Clindamycin are used for the therapy.

COMBINATION_PRODUCT

Suppositoria for vaginal microflora recovery (Giynoflor)

Prescription of suppositoria for vaginal microflora recovery after antibiotic therapy. Probiotic grug includes Lactobacilli acidophillis as the main compound.

DRUG

Antifungal therapy (Mostly Fluconazole, Nystatin, Amphotericin B)

Prescription of antifungal drugs. Triazoles (Fluconazole, Itraconazole, Voriconazole), Imidazoles (Ketoconazole), Nystatin and Amphotericin B are used the most

Trial Locations (1)

79000

Danylo Halytsky Lviv National Medical University, Lviv

All Listed Sponsors

lead

Danylo Halytsky Lviv National Medical University

OTHER